Mycobacterium bovis discitis as a complication of intravesical Bacillus Calmette-Guérin therapy

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Alexandra N Colebatch, Karen E Mounce

Abstract

We report a culture-proven case of Mycobacterium bovis discitis in a 67-year-old man who had received intravesical Bacillus Calmette-Guérin for bladder cancer 5 years previously. He presented with severe low back pain, and imaging revealed features of discitis and paraspinal abscesses. On aspiration of the abnormal tissue, culture confirmed infection with M. bovis. Quadruple antituberculous therapy was commenced at this stage, with a subsequent good clinical response. Hematogenous spread of M. bovis is a rare, often delayed, complication of intravesical BCG therapy, but early appropriate treatment can result in a good prognosis.

References

Jun 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R CivenC Panosian
Mar 1, 1993·The Journal of Urology·J R FishmanR W deVere White
Sep 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L Lamm
Apr 9, 2002·Mayo Clinic Proceedings·Rima Abu-Nader, Christine L Terrell

❮ Previous
Next ❯

Citations

Oct 13, 2012·Journal of the American Geriatrics Society·Alexandre ForsterNikolaos Samaras
Nov 23, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Emilie Stavnsbjerg LarsenIsik Somuncu Johansen
Apr 30, 2019·JAAPA : Official Journal of the American Academy of Physician Assistants·Cheryl L Heck, Gary T Schwartzbauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.